InfiniHealth Medical Group today announced the continued advancement of its integrated multispecialty care model, a clinical ...

A supplement made from broccoli, green tea, and turmeric has slowed the rise of a prostate cancer blood marker in men monitored for early disease. That slowdown reframes how long some patients may ...

Swedish freestyle skier Elis Lundholm will be the first transgender athlete in Winter Olympic Games. It has created global interest and controversy in an already contentious issue about inclusion ...

Convicted sex offender Jeffrey Epstein was treated for a myriad of health issues, including low testosterone and at least one sexually transmitted infection (STI), according to new reporting on the ...

The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially ...

The controversial venture allows athletes to use performance-enhancing drugs, sparking health concerns from traditional sporting bodies ...

Some men are resorting to obtaining testosterone replacement therapy (TRT) from underground sources due to significant ...

The conversation featured Dr. Melvin Fussell, a board-certified urologist and founder of UroHard, who shared candid insights ...

The controversial boxer sat down with a French newspaper, where she revealed that she's intersex and takes hormones to keep ...

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...